This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Cardiovascular
Torsemide and furosemide all-cause mortality similar in heart failure
Read more
Predictive model identifies factors linked to metformin failure in type 2 diabetics
Read more
Metomidate scan enables diagnosis of primary aldosteronism
Read more
Herpes zoster infection linked to higher risk of stroke and coronary heart disease
Read more
Coronary artery calcium score and cystatin C level combined predict MACCE in chest pain
Read more
Drinking coffee and tea significantly reduces cardiovascular disease mortality
Read more
Higher lipoprotein A in hypertensives increases risk of adverse cardiovascular events
Read more
Review suggests GLP1 agonists offer similar glycaemic control to bariatric surgery
Read more
Aprocitentan superior to placebo in resistant hypertension
Read more
PCSK9 inhibitor persistence in FH high in clinical practice
Read more
Highly purified EPA reduces adverse cardiovascular events in at-risk patients
Read more
AI model predicts CVD risk from single chest radiograph
Read more
Morning physical activity linked to lowest risk of cardiovascular disease
Read more
Statin induced muscle symptoms not improved with vitamin D
Read more
Longer rivaroxaban course reduces risk of recurrent venous thromboembolism
Read more
Higher olive oil intake linked to lower CVD and all-cause mortality risk
Read more
Review finds honey improves cardiometabolic risk factors
Read more
Page 9 of 39
« First
«
...
7
8
9
10
11
...
20
30
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: